Literature DB >> 16265597

Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Joanna S Fowler1, Jean Logan, Nora D Volkow, Gene-Jack Wang.   

Abstract

Positron emission tomography (PET) using radiotracers with high molecular specificity is an important scientific tool in studies of monoamine oxidase (MAO), an important enzyme in the regulation of the neurotransmitters dopamine, norepinephrine, and serotonin as well as the dietary amine, tyramine. MAO occurs in two different subtypes, MAO A and MAO B, which have different substrate and inhibitor specificity and which are different gene products. The highly variable subtype distribution with different species makes human studies of special value. MAO A and B can be imaged in the human brain and certain peripheral organs using PET and carbon-11 (half-life 20.4 minutes) labeled mechanism-based irreversible inhibitors, clorgyline and L -deprenyl, respectively. In this article we introduce MAO and describe the development of these radiotracers and their translation from preclinical studies to the investigation of variables affecting MAO in the human brain and peripheral organs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16265597     DOI: 10.1007/s11307-005-0016-1

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  83 in total

1.  Genetics. Rethinking behavior genetics.

Authors:  Dean Hamer
Journal:  Science       Date:  2002-10-04       Impact factor: 47.728

2.  Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

Authors:  J S Fowler; R R MacGregor; A P Wolf; C D Arnett; S L Dewey; D Schlyer; D Christman; J Logan; M Smith; H Sachs
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

3.  Localization of monoamine oxidases in human peripheral tissues.

Authors:  J Saura; E Nadal; B van den Berg; M Vila; J A Bombi; N Mahy
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

4.  Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain.

Authors:  J S Fowler; N D Volkow; J Logan; D Franceschi; G J Wang; R MacGregor; C Shea; V Garza; N Pappas; P Carter; N Netusil; P Bridge; D Liederman; A Elkashef; J Rotrosen; R Hitzemann
Journal:  Life Sci       Date:  2001-05-04       Impact factor: 5.037

5.  Neocortical cell counts in normal human adult aging.

Authors:  R D Terry; R DeTeresa; L A Hansen
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

Review 6.  Pharmacogenetics and the serotonin system: initial studies and future directions.

Authors:  J Veenstra-VanderWeele; G M Anderson; E H Cook
Journal:  Eur J Pharmacol       Date:  2000-12-27       Impact factor: 4.432

Review 7.  PET and drug research and development.

Authors:  J S Fowler; N D Volkow; G J Wang; Y S Ding; S L Dewey
Journal:  J Nucl Med       Date:  1999-07       Impact factor: 10.057

8.  Low monoamine oxidase B in peripheral organs in smokers.

Authors:  Joanna S Fowler; Jean Logan; Gene-Jack Wang; Nora D Volkow; Frank Telang; Wei Zhu; Dinko Franceschi; Naomi Pappas; Richard Ferrieri; Colleen Shea; Victor Garza; Youwen Xu; David Schlyer; S John Gatley; Yu-Shin Ding; David Alexoff; Donald Warner; Noelwah Netusil; Pauline Carter; Millard Jayne; Payton King; Paul Vaska
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

9.  A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation.

Authors:  Tony P George; Jennifer C Vessicchio; Angelo Termine; Peter I Jatlow; Thomas R Kosten; Stephanie S O'Malley
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

Review 10.  Organization of MAO A and MAO B promoters and regulation of gene expression.

Authors:  Kevin Chen
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more
  29 in total

1.  Serotonin Syndrome following Introduction of Venlafaxine following Withdrawal of Phenelzine: Implications for Drug Washout Periods.

Authors:  Sarah J Yates; Niraj Ahuja; Sarah E Gartside; R Hamish McAllister-Williams
Journal:  Ther Adv Psychopharmacol       Date:  2011-08

2.  PET radiopharmaceuticals for probing enzymes in the brain.

Authors:  Jason P Holland; Paul Cumming; Neil Vasdev
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

Review 3.  Modeling of PET data in CNS drug discovery and development.

Authors:  Katarina Varnäs; Andrea Varrone; Lars Farde
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-05-10       Impact factor: 2.745

Review 4.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

5.  Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.

Authors:  Jin Wang; Dale E Edmondson
Journal:  Biochemistry       Date:  2011-03-07       Impact factor: 3.162

Review 6.  Neuroimaging for drug addiction and related behaviors.

Authors:  Muhammad A Parvaz; Nelly Alia-Klein; Patricia A Woicik; Nora D Volkow; Rita Z Goldstein
Journal:  Rev Neurosci       Date:  2011-11-25       Impact factor: 4.353

7.  Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells.

Authors:  Dalip Sethi; Chang-Po Chen; Rui-Yan Jing; Mathew L Thakur; Eric Wickstrom
Journal:  Bioconjug Chem       Date:  2012-01-25       Impact factor: 4.774

8.  In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multi-injection approach.

Authors:  Michel Bottlaender; Héric Valette; Jacques Delforge; Wadad Saba; Ilonka Guenther; Olivier Curet; Pascal George; Frédéric Dollé; Marie-Claude Grégoire
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-18       Impact factor: 6.200

9.  Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders?

Authors:  Ruben D Baler; Nora D Volkow; Joanna S Fowler; Helene Benveniste
Journal:  J Psychiatry Neurosci       Date:  2008-05       Impact factor: 6.186

10.  Brain monoamine oxidase A activity predicts trait aggression.

Authors:  Nelly Alia-Klein; Rita Z Goldstein; Aarti Kriplani; Jean Logan; Dardo Tomasi; Benjamin Williams; Frank Telang; Elena Shumay; Anat Biegon; Ian W Craig; Fritz Henn; Gene-Jack Wang; Nora D Volkow; Joanna S Fowler
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.